IRINA MILGRAM: Open Payments
NPI 1285823559 · EAST BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,184 in 124 payments from 23 companies in 2025. Trend: 2023 $1,287 · 2024 $1,832 · 2025 $2,184
Food & beverage: $2,089Education: $95
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 15 | $314 |
| ABBVIE INC. | 20 | $295 |
| Janssen Biotech, Inc. | 8 | $210 |
| Galderma Laboratories, L.P. | 14 | $180 |
| PFIZER INC. | 4 | $168 |
| Novartis Pharmaceuticals Corporation | 4 | $123 |
| Organon LLC | 13 | $118 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $100 |
| Lilly USA, LLC | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 5 | $79 |
Products named: OPZELURA, SKYRIZI, TREMFYA, CIBINQO, NEMLUVIO, DUPIXENT, Cabtreo, Bimzelx.
Industry payments across NJ — which companies pay providers there.
